What Is Semaglutide and How Does It Work?
An evidence-based primer on GLP-1 receptor agonists — mechanism, dosing logic, and why the clinical outcomes are rewriting metabolic medicine.
Read →Clinical research, protocol guidance, and performance intelligence — for people who want to understand the why.
The landmark tirzepatide trial didn't just demonstrate efficacy. It redefined what was achievable in metabolic medicine without surgery. Here's what the data actually shows.
Read Article →An evidence-based primer on GLP-1 receptor agonists — mechanism, dosing logic, and why the clinical outcomes are rewriting metabolic medicine.
Read →NAD+ is foundational to cellular energy production and DNA repair. The decline after 40 is measurable — and so is the intervention.
Read →Weight loss always raises the question of lean mass retention. Here's what the trial data actually shows about muscle preservation during GLP-1 therapy.
Read →The Androgen Deficiency in Aging Males questionnaire is the clinical standard for initial hypogonadism screening. Here's how it works and what it's measuring.
Read →Not all pharmacies are equal. Understanding the difference between 503A and 503B facilities — and why AnthologyRX uses the latter for every protocol.
Read →Combining a GHRH analog with a ghrelin mimetic creates a synergistic growth hormone pulse. Here's the clinical rationale behind the most popular peptide combination.
Read →A first-person account of the protocol experience — from intake to outcomes. Real results, in their own words.
Read →Coming soon. Emerging science on longevity medicine and practical interventions for the performance-focused individual.
Read →Coming soon. Performance-focused coverage of the latest research in peptide therapy, hormonal optimization, and elite-level recovery protocols.
Read →The protocols are live. Your assessment takes three minutes.
See If You Qualify →